β-catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours

International Journal of Cancer

Volumn 82, Issue 5, 1999, Pages 625-629

  Wright, Kim ^a   Wilson, Peter ^a   Morland, Sarah ^b   Campbell, Ian ^b   Walsh, Michael ^a   Hurst, Terry ^a   Ward, Bruce ^a   Cummings, Margaret ^a   Chenevix Trench, Georgia ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; TRANSACTIVATOR PROTEIN; GLYCINE; LYMPHOID ENHANCER FACTOR 1; SERINE;

ARTICLE; BIOSYNTHESIS; CELL NUCLEUS; DISEASE COURSE; EXON; FEMALE; GENE REARRANGEMENT; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MUTATION; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; ENDOMETRIOID CARCINOMA; GENE MUTATION; GENE TRANSLOCATION; HUMAN CELL; HUMAN TISSUE; MISSENSE MUTATION; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DOMAIN;

BETA CATENIN; BIOLOGICAL TRANSPORT; CELL NUCLEUS; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE REARRANGEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; OVARIAN NEOPLASMS; TRANS-ACTIVATORS;

EID: 0033609680     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990827)82:5<625::AID-IJC1>3.0.CO;2-2     Document Type: Article

References (26)

1. ABERLE, H., BAUER, A., STAPPERT, J., KISPERT, A. and KEMLER, R., β-Catenin is a target for the ubiquitin-proteosome pathway. EMBO J., 16, 3797-3804(1997).
2. ABERLE, H., BUTZ, S., STAPPERT, J., WEISSIG, H., KEMLER, R. and HOSCHUETZKY, H., Assembly of the cadherin-catenin complex in vitro with recombinant proteins, J. Cell Sci., 12, 3655-3663(1994).
3. ALLAN, G.J., COTTRELL, S., TROWSDALE, J. and FOULKES, W.D., Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and not associated with mutation in APC at 5q21-22. Hum. Mutation, 3, 283-291(1994).
4. BEHRENS, J., VON KRIES, J.P., KUHL, M., BRUHN, L., WEDLICH, D., GROSSCHEDL, R. and BIRCHMEIER, W., Functional interactions of β-catenin with the transcription factor LEF-1. Nature, 382, 638-642 (1996).
5. BULLIONS, L.C., NOTTERMAN, D.A., CHUNG, L.S., LEVINE, A.J., ALLAN, G.J., COTTRELL, S., TROWSDALE, J. and FOULKES, W.D., Expression of wild-type α-catenin protein in cells with a mutant α-catenin gene restores both growth regulation and tumour suppressor activity. Mol. cell. Biol., 17, 4501-4508 (1997).
6. CHENEVIX-TRENCH, G., KERR, J., FRIEDLANDER, M., HURST, T., SANDERSON, B., COGLAN, M., WARD, B., LEARY, J. and KHOO, S.-K., Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumours. Amer. J. hum. Genet., 55, 143-149 (1994).
7. CHENEVIX-TRENCH, G., LEARY, J., KERR, J., KEFFORD, J.M.R., HURST, T., PARSONS, P.G., FRIEDLANDER, M. and KHOO, S.K., Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma does not always include the DCC locus. Oncogene, 7, 1059-1065 (1992).
8. FUKUCHI, T., SAKAMOTO, M., TSUDA, H., MARUYAMA, K., NOZAWA, S. and HIROHASHI, S., β-Catenin mutations in carcinoma of the uterine endometrium. Cancer Res., 58, 3526-3528 (1998).
9. HE, T.-C., SPARKS, A.B., RAGO, C., HERMEKING, H., ZAWEL, L., DA COSTA, L.T., MORIN, P.J., VOGELSTEIN, B. and KINZLER, K.W., Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512 (1998).
10. IWAO, K., NAKAMORI, S., KAMEYAMA, M., IMAOKA, S., KINOSHITA, M., FUKUI, T., ISHIGURO, S., NAKAMURA, Y. and MIYOSHI, Y., Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res., 58, 1021-1026 (1998).
11. KOHLER, M., MARKS, J. and WISEMAN, R., Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J. nat. Cancer Inst., 85, 1513-1519 (1993).
12. LEVI, S., URBANO-ISPIZUA, A., GILL, R., THOMAS, D.M., GILBERTSON, J., FOSTER, C. and MARSHALL, C.J., Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res., 51, 3497-3502 (1991).
13. MILLER, J.R. and MOON, R.T., Signal transduction through β-catenin and specification of cell fate during embryogenesis. Genes Develop., 10, 2527-2539 (1996).
14. MORIN, P.J. and 15 others, Activation of β-catenin-Tcf signalling in colon cancer by mutations in β-catenin or APC. Science, 275, 1787-1790 (1997).
15. OBATA, K., MORLAND, S.J., WATSON, R.H., HITCHCOCK, A., CHENEVIX-TRENCH, G., THOMAS, E.J. and CAMPBELL, I.G., Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumours. Cancer Res., 58, 2095-2097 (1998).
16. ORFORD, K., CROCKETT, C., JENSEN, J.P., WEISSMAN, A.M. and BYERS, S.W., Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. biol. Chem., 272, 24735-24738 (1997).
17. PALACIOS, J. and GAMALLO, C., Mutations in the β-catenin (CTNNBI) in endometrioid ovarian cancers. Cancer Res., 58, 1344-1347 (1998).
18. PARKIN, D.M., PISANI, P. and FERLAY, J., Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54, 594-606 (1993).
19. PEIFER, M., Cell adhesion and signal transduction: the armadillo connection. Trends Cell Biol., 5, 224-229 (1995).
20. PEJOVIC, T., Genetic changes in ovarian cancer. Ann. Med., 27, 73-78 (1995).
21. RUBINFELD, B., ROBBINS, P., EL-GAMIL, M., ALBERT, I., PORFIRI, E. and POLAKIS, P., Stabilisation of β-catenin by genetic defects in melanoma cell lines. Science, 275, 1790-1792 (1997).
22. SIMCHA, I., SHTUTMAN, M., SALOMON, D., ZHURINSKY, J., SADOT, E., GEIGER, B. and BEN ZE'EV, A., Differential nuclear translocation and transactivation potential of β-catenin and plakoglobulin. J. Cell Biol., 141, 1433-1448 (1998).
23. SPARKS, A.B., MORIN, P.J., VOGELSTEIN, B. and KINZLER, K.W., Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58, 1130-1134 (1998).
24. TAKAHASHI, M., FUKUDA, K., SUGIMURA, T. and WAKABAYASHI, K., β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumours. Cancer Res., 58, 42-46 (1998).
25. TENERIELLO, M.G., EBINA, M., LINNOILA, R.I., HENRY, M., NASH, J.D., PARK, R.C. and BIRRER, M.J., p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res., 53, 3103-3108 (1993).
26. YOST, C., TORRES, M., MILLER, R.R., HUANG, E., KIMELMAN, D. and MOON, R.T., The axis-inducing activity, stability, and sub-cellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Develop., 10, 1443-1454 (1996).